News
Industry acknowledgements
We provide breakthrough approaches with our patented IP in sRNA research
Isomicro-RNAs’ levels in blood as measured by assay
FDA Letter of Support
Salzman DW
Biomarkers for the early-detection and monitoring of Huntington’s disease
7th World CNS Summit: Targeting Neurodegenerative Diseases, Boston, MA (2019)
Salzman DW, Bregu J, Ray NS, Myers RH
Biomarkers for the early-detection and monitoring of Huntington’s Disease
RNA-Based Biomarker Grant (completion 2021)
Salzman DW, Bregu J, Ray NS, Myers RH
An AI-driven platform to classify and subtype CNS disease using small RNAs
Neuroimaging and CSF Biomarker Development Grant (completion 2021)
Salzman DW, Melconian T, Foster N, Ray NS
